The global market for AI Drug Design was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

AI drug design refers to the use of artificial intelligence and computational methods to discover, design, and develop new pharmaceutical drugs. By employing machine learning algorithms, AI Drug Design can analyze vast amounts of chemical and biological data, predict drug-target interactions, generate virtual compound libraries, and propose potential drug candidates. It aims to accelerate the drug discovery process, improve the success rate of candidate molecules, and facilitate the development of more effective and targeted medications.

North American market for AI Drug Design is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for AI Drug Design is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for AI Drug Design in Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of AI Drug Design include Exscientia, PathAI, Tempus, Aria Pharmaceuticals, BenchSci, Antidote, AiCure, Atomwise, Envisagenics, Sherlock, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for AI Drug Design, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Drug Design.

The AI Drug Design market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI Drug Design market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the AI Drug Design companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of AI Drug Design Market Report

Report Metric	Details
Report Name	AI Drug Design Market
Segment by Type	Therapy Research Design and Development Others
Segment by Application	Cancer Cardiovascular Disease Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Exscientia, PathAI, Tempus, Aria Pharmaceuticals, BenchSci, Antidote, AiCure, Atomwise, Envisagenics, Sherlock, Deep Genomics, Benevolent, Iktos, AlmirallShare
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI Drug Design company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the AI Drug Design Market report?

Ans: The main players in the AI Drug Design Market are Exscientia, PathAI, Tempus, Aria Pharmaceuticals, BenchSci, Antidote, AiCure, Atomwise, Envisagenics, Sherlock, Deep Genomics, Benevolent, Iktos, AlmirallShare

What are the Application segmentation covered in the AI Drug Design Market report?

Ans: The Applications covered in the AI Drug Design Market report are Cancer, Cardiovascular Disease, Others

What are the Type segmentation covered in the AI Drug Design Market report?

Ans: The Types covered in the AI Drug Design Market report are Therapy Research, Design and Development, Others

Recommended Reports

AI Drug Discovery

AI Diagnostics

Drug Modeling Software

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI Drug Design Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Therapy Research

1.2.3 Design and Development

1.2.4 Others

1.3 Market by Application

1.3.1 Global AI Drug Design Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer

1.3.3 Cardiovascular Disease

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global AI Drug Design Market Perspective (2020-2031)

2.2 Global AI Drug Design Growth Trends by Region

2.2.1 Global AI Drug Design Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 AI Drug Design Historic Market Size by Region (2020-2025)

2.2.3 AI Drug Design Forecasted Market Size by Region (2026-2031)

2.3 AI Drug Design Market Dynamics

2.3.1 AI Drug Design Industry Trends

2.3.2 AI Drug Design Market Drivers

2.3.3 AI Drug Design Market Challenges

2.3.4 AI Drug Design Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top AI Drug Design Players by Revenue

3.1.1 Global Top AI Drug Design Players by Revenue (2020-2025)

3.1.2 Global AI Drug Design Revenue Market Share by Players (2020-2025)

3.2 Global AI Drug Design Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by AI Drug Design Revenue

3.4 Global AI Drug Design Market Concentration Ratio

3.4.1 Global AI Drug Design Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI Drug Design Revenue in 2024

3.5 Global Key Players of AI Drug Design Head office and Area Served

3.6 Global Key Players of AI Drug Design, Product and Application

3.7 Global Key Players of AI Drug Design, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 AI Drug Design Breakdown Data by Type

4.1 Global AI Drug Design Historic Market Size by Type (2020-2025)

4.2 Global AI Drug Design Forecasted Market Size by Type (2026-2031)

5 AI Drug Design Breakdown Data by Application

5.1 Global AI Drug Design Historic Market Size by Application (2020-2025)

5.2 Global AI Drug Design Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America AI Drug Design Market Size (2020-2031)

6.2 North America AI Drug Design Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America AI Drug Design Market Size by Country (2020-2025)

6.4 North America AI Drug Design Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe AI Drug Design Market Size (2020-2031)

7.2 Europe AI Drug Design Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe AI Drug Design Market Size by Country (2020-2025)

7.4 Europe AI Drug Design Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific AI Drug Design Market Size (2020-2031)

8.2 Asia-Pacific AI Drug Design Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific AI Drug Design Market Size by Region (2020-2025)

8.4 Asia-Pacific AI Drug Design Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America AI Drug Design Market Size (2020-2031)

9.2 Latin America AI Drug Design Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America AI Drug Design Market Size by Country (2020-2025)

9.4 Latin America AI Drug Design Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa AI Drug Design Market Size (2020-2031)

10.2 Middle East & Africa AI Drug Design Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa AI Drug Design Market Size by Country (2020-2025)

10.4 Middle East & Africa AI Drug Design Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Exscientia

11.1.1 Exscientia Company Details

11.1.2 Exscientia Business Overview

11.1.3 Exscientia AI Drug Design Introduction

11.1.4 Exscientia Revenue in AI Drug Design Business (2020-2025)

11.1.5 Exscientia Recent Development

11.2 PathAI

11.2.1 PathAI Company Details

11.2.2 PathAI Business Overview

11.2.3 PathAI AI Drug Design Introduction

11.2.4 PathAI Revenue in AI Drug Design Business (2020-2025)

11.2.5 PathAI Recent Development

11.3 Tempus

11.3.1 Tempus Company Details

11.3.2 Tempus Business Overview

11.3.3 Tempus AI Drug Design Introduction

11.3.4 Tempus Revenue in AI Drug Design Business (2020-2025)

11.3.5 Tempus Recent Development

11.4 Aria Pharmaceuticals

11.4.1 Aria Pharmaceuticals Company Details

11.4.2 Aria Pharmaceuticals Business Overview

11.4.3 Aria Pharmaceuticals AI Drug Design Introduction

11.4.4 Aria Pharmaceuticals Revenue in AI Drug Design Business (2020-2025)

11.4.5 Aria Pharmaceuticals Recent Development

11.5 BenchSci

11.5.1 BenchSci Company Details

11.5.2 BenchSci Business Overview

11.5.3 BenchSci AI Drug Design Introduction

11.5.4 BenchSci Revenue in AI Drug Design Business (2020-2025)

11.5.5 BenchSci Recent Development

11.6 Antidote

11.6.1 Antidote Company Details

11.6.2 Antidote Business Overview

11.6.3 Antidote AI Drug Design Introduction

11.6.4 Antidote Revenue in AI Drug Design Business (2020-2025)

11.6.5 Antidote Recent Development

11.7 AiCure

11.7.1 AiCure Company Details

11.7.2 AiCure Business Overview

11.7.3 AiCure AI Drug Design Introduction

11.7.4 AiCure Revenue in AI Drug Design Business (2020-2025)

11.7.5 AiCure Recent Development

11.8 Atomwise

11.8.1 Atomwise Company Details

11.8.2 Atomwise Business Overview

11.8.3 Atomwise AI Drug Design Introduction

11.8.4 Atomwise Revenue in AI Drug Design Business (2020-2025)

11.8.5 Atomwise Recent Development

11.9 Envisagenics

11.9.1 Envisagenics Company Details

11.9.2 Envisagenics Business Overview

11.9.3 Envisagenics AI Drug Design Introduction

11.9.4 Envisagenics Revenue in AI Drug Design Business (2020-2025)

11.9.5 Envisagenics Recent Development

11.10 Sherlock

11.10.1 Sherlock Company Details

11.10.2 Sherlock Business Overview

11.10.3 Sherlock AI Drug Design Introduction

11.10.4 Sherlock Revenue in AI Drug Design Business (2020-2025)

11.10.5 Sherlock Recent Development

11.11 Deep Genomics

11.11.1 Deep Genomics Company Details

11.11.2 Deep Genomics Business Overview

11.11.3 Deep Genomics AI Drug Design Introduction

11.11.4 Deep Genomics Revenue in AI Drug Design Business (2020-2025)

11.11.5 Deep Genomics Recent Development

11.12 Benevolent

11.12.1 Benevolent Company Details

11.12.2 Benevolent Business Overview

11.12.3 Benevolent AI Drug Design Introduction

11.12.4 Benevolent Revenue in AI Drug Design Business (2020-2025)

11.12.5 Benevolent Recent Development

11.13 Iktos

11.13.1 Iktos Company Details

11.13.2 Iktos Business Overview

11.13.3 Iktos AI Drug Design Introduction

11.13.4 Iktos Revenue in AI Drug Design Business (2020-2025)

11.13.5 Iktos Recent Development

11.14 AlmirallShare

11.14.1 AlmirallShare Company Details

11.14.2 AlmirallShare Business Overview

11.14.3 AlmirallShare AI Drug Design Introduction

11.14.4 AlmirallShare Revenue in AI Drug Design Business (2020-2025)

11.14.5 AlmirallShare Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global AI Drug Design Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Therapy Research

Table 3. Key Players of Design and Development

Table 4. Key Players of Others

Table 5. Global AI Drug Design Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global AI Drug Design Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global AI Drug Design Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global AI Drug Design Market Share by Region (2020-2025)

Table 9. Global AI Drug Design Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global AI Drug Design Market Share by Region (2026-2031)

Table 11. AI Drug Design Market Trends

Table 12. AI Drug Design Market Drivers

Table 13. AI Drug Design Market Challenges

Table 14. AI Drug Design Market Restraints

Table 15. Global AI Drug Design Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global AI Drug Design Market Share by Players (2020-2025)

Table 17. Global Top AI Drug Design Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Design as of 2024)

Table 18. Ranking of Global Top AI Drug Design Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by AI Drug Design Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of AI Drug Design, Headquarters and Area Served

Table 21. Global Key Players of AI Drug Design, Product and Application

Table 22. Global Key Players of AI Drug Design, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global AI Drug Design Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global AI Drug Design Revenue Market Share by Type (2020-2025)

Table 26. Global AI Drug Design Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global AI Drug Design Revenue Market Share by Type (2026-2031)

Table 28. Global AI Drug Design Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global AI Drug Design Revenue Market Share by Application (2020-2025)

Table 30. Global AI Drug Design Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global AI Drug Design Revenue Market Share by Application (2026-2031)

Table 32. North America AI Drug Design Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America AI Drug Design Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America AI Drug Design Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe AI Drug Design Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe AI Drug Design Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe AI Drug Design Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific AI Drug Design Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific AI Drug Design Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific AI Drug Design Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America AI Drug Design Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America AI Drug Design Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America AI Drug Design Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa AI Drug Design Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa AI Drug Design Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa AI Drug Design Market Size by Country (2026-2031) & (US$ Million)

Table 47. Exscientia Company Details

Table 48. Exscientia Business Overview

Table 49. Exscientia AI Drug Design Product

Table 50. Exscientia Revenue in AI Drug Design Business (2020-2025) & (US$ Million)

Table 51. Exscientia Recent Development

Table 52. PathAI Company Details

Table 53. PathAI Business Overview

Table 54. PathAI AI Drug Design Product

Table 55. PathAI Revenue in AI Drug Design Business (2020-2025) & (US$ Million)

Table 56. PathAI Recent Development

Table 57. Tempus Company Details

Table 58. Tempus Business Overview

Table 59. Tempus AI Drug Design Product

Table 60. Tempus Revenue in AI Drug Design Business (2020-2025) & (US$ Million)

Table 61. Tempus Recent Development

Table 62. Aria Pharmaceuticals Company Details

Table 63. Aria Pharmaceuticals Business Overview

Table 64. Aria Pharmaceuticals AI Drug Design Product

Table 65. Aria Pharmaceuticals Revenue in AI Drug Design Business (2020-2025) & (US$ Million)

Table 66. Aria Pharmaceuticals Recent Development

Table 67. BenchSci Company Details

Table 68. BenchSci Business Overview

Table 69. BenchSci AI Drug Design Product

Table 70. BenchSci Revenue in AI Drug Design Business (2020-2025) & (US$ Million)

Table 71. BenchSci Recent Development

Table 72. Antidote Company Details

Table 73. Antidote Business Overview

Table 74. Antidote AI Drug Design Product

Table 75. Antidote Revenue in AI Drug Design Business (2020-2025) & (US$ Million)

Table 76. Antidote Recent Development

Table 77. AiCure Company Details

Table 78. AiCure Business Overview

Table 79. AiCure AI Drug Design Product

Table 80. AiCure Revenue in AI Drug Design Business (2020-2025) & (US$ Million)

Table 81. AiCure Recent Development

Table 82. Atomwise Company Details

Table 83. Atomwise Business Overview

Table 84. Atomwise AI Drug Design Product

Table 85. Atomwise Revenue in AI Drug Design Business (2020-2025) & (US$ Million)

Table 86. Atomwise Recent Development

Table 87. Envisagenics Company Details

Table 88. Envisagenics Business Overview

Table 89. Envisagenics AI Drug Design Product

Table 90. Envisagenics Revenue in AI Drug Design Business (2020-2025) & (US$ Million)

Table 91. Envisagenics Recent Development

Table 92. Sherlock Company Details

Table 93. Sherlock Business Overview

Table 94. Sherlock AI Drug Design Product

Table 95. Sherlock Revenue in AI Drug Design Business (2020-2025) & (US$ Million)

Table 96. Sherlock Recent Development

Table 97. Deep Genomics Company Details

Table 98. Deep Genomics Business Overview

Table 99. Deep Genomics AI Drug Design Product

Table 100. Deep Genomics Revenue in AI Drug Design Business (2020-2025) & (US$ Million)

Table 101. Deep Genomics Recent Development

Table 102. Benevolent Company Details

Table 103. Benevolent Business Overview

Table 104. Benevolent AI Drug Design Product

Table 105. Benevolent Revenue in AI Drug Design Business (2020-2025) & (US$ Million)

Table 106. Benevolent Recent Development

Table 107. Iktos Company Details

Table 108. Iktos Business Overview

Table 109. Iktos AI Drug Design Product

Table 110. Iktos Revenue in AI Drug Design Business (2020-2025) & (US$ Million)

Table 111. Iktos Recent Development

Table 112. AlmirallShare Company Details

Table 113. AlmirallShare Business Overview

Table 114. AlmirallShare AI Drug Design Product

Table 115. AlmirallShare Revenue in AI Drug Design Business (2020-2025) & (US$ Million)

Table 116. AlmirallShare Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

Table 120. Authors List of This Report

List of Figures

Figure 1. AI Drug Design Picture

Figure 2. Global AI Drug Design Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global AI Drug Design Market Share by Type: 2024 VS 2031

Figure 4. Therapy Research Features

Figure 5. Design and Development Features

Figure 6. Others Features

Figure 7. Global AI Drug Design Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global AI Drug Design Market Share by Application: 2024 VS 2031

Figure 9. Cancer Case Studies

Figure 10. Cardiovascular Disease Case Studies

Figure 11. Others Case Studies

Figure 12. AI Drug Design Report Years Considered

Figure 13. Global AI Drug Design Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global AI Drug Design Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global AI Drug Design Market Share by Region: 2024 VS 2031

Figure 16. Global AI Drug Design Market Share by Players in 2024

Figure 17. Global Top AI Drug Design Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Design as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by AI Drug Design Revenue in 2024

Figure 19. North America AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America AI Drug Design Market Share by Country (2020-2031)

Figure 21. United States AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe AI Drug Design Market Share by Country (2020-2031)

Figure 25. Germany AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific AI Drug Design Market Share by Region (2020-2031)

Figure 33. China AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America AI Drug Design Market Share by Country (2020-2031)

Figure 41. Mexico AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa AI Drug Design Market Share by Country (2020-2031)

Figure 45. Turkey AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE AI Drug Design Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Exscientia Revenue Growth Rate in AI Drug Design Business (2020-2025)

Figure 49. PathAI Revenue Growth Rate in AI Drug Design Business (2020-2025)

Figure 50. Tempus Revenue Growth Rate in AI Drug Design Business (2020-2025)

Figure 51. Aria Pharmaceuticals Revenue Growth Rate in AI Drug Design Business (2020-2025)

Figure 52. BenchSci Revenue Growth Rate in AI Drug Design Business (2020-2025)

Figure 53. Antidote Revenue Growth Rate in AI Drug Design Business (2020-2025)

Figure 54. AiCure Revenue Growth Rate in AI Drug Design Business (2020-2025)

Figure 55. Atomwise Revenue Growth Rate in AI Drug Design Business (2020-2025)

Figure 56. Envisagenics Revenue Growth Rate in AI Drug Design Business (2020-2025)

Figure 57. Sherlock Revenue Growth Rate in AI Drug Design Business (2020-2025)

Figure 58. Deep Genomics Revenue Growth Rate in AI Drug Design Business (2020-2025)

Figure 59. Benevolent Revenue Growth Rate in AI Drug Design Business (2020-2025)

Figure 60. Iktos Revenue Growth Rate in AI Drug Design Business (2020-2025)

Figure 61. AlmirallShare Revenue Growth Rate in AI Drug Design Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions